LubioScience launches Next Generation Sequencing services in Switzerland
LubioScience GmbH, Switzerland’s leading Life Sciences platform, announces the launch of Next Generation Sequencing (NGS) services to expand its custom services offering.
LubioScience now offers a range of NGS services, including RNA sequencing, microRNA sequencing, metagenomic sequencing and epigenetic services to researchers in Switzerland.
Acceptable sample types include blood, cells, tissue, urine, plants and others. The NGS services offering is optimized towards challenging samples, such as ultra-low inputs from liquid biopsies and exosomes. LubioScience offers a complete service workflow, from project design to RNA isolation, library preparation, sequencing and advanced bioinformatic analysis for ready-to-publish data. Sequencing is performed in accredited state-of-the art laboratories, using Illumina® Sequencing Platforms.
“We're excited to expand our custom services portfolio by offering Next Generation Sequencing services to provide our clients with fast, scalable solutions for a clear, complete picture of their samples to advance their scientific discoveries.” says Dr. Muriel Revol, Director of Custom Services. The complete range of LubioScience custom services is also available via Scientist.com.
About LubioScience
LubioScience is Switzerland's fastest growing Life Sciences distributor. Their portfolio covers over 5 million products from more than 120 suppliers, including the largest portfolio of antibodies, proteins and assays kits in Switzerland. LubioScience is proud to be a carbon neutral company and we compensate our full carbon footprint by investing in reforestation projects in Central Africa. LubioScience is a preferred supplier of the Swiss Biotech Association and a member of the Pivotal Scientific Limited Alliance.